Fundraising

Lumira Capital IV wins commitment from BC Tech Fund

BC Tech Fund has made an undisclosed commitment to Lumira Capital IV, the fourth healthcare and life sciences fund of Canadian venture capital firm Lumira Capital. Dr. Richard Glickman, chairman and CEO of Victoria, British Columbia-based Aurinia Pharmaceuticals Inc (Nasdaq: AUPH, TSX: AUP), a Lumira portfolio company, was concurrently named a partner at the firm. Earlier this week, Vancouver's Zymeworks Inc, another Lumira portfolio company, filed to go public. Capitalized at $100 million, BC Tech Fund was launched last year under the management of Kensington Capital Partners.

Base raises $8.8 mln toward second venture fund

Base Ventures has raised $8.8 million toward a $10 million second fund, according to a filing from the SEC.

Cloud Apps Capital Partners to raise $100 mln second fund

Cloud Apps Capital Partners has set out to raise a $100 million second fund, according to a filing with the SEC.

Semil Shah's Haystack seeks $25 mln for fourth fund

WestSummit targets $300 mln for third tech fund

WestSummit Capital is seeking to raise $300 million for its third tech fund, according to an SEC filing. Based in Silicon Valley, Beijing and Hong Kong, WestSummit invests in tech companies in North America and China.

Haystack seeks $25 mln for Fund IV

Early-stage investor Haystack Ventures, led by founder Semil Shah, is seeking $25 million or its fourth fund, according to a regulatory filing. The fund is the same size as Fund III.

Fund performance: Column Group leads a solid mid-decade portfolio at UC

Balderton sets sights on sixth venture fund

Balderton to raise a sixth venture fund

Balderton Capital has set out to raise a sixth venture fund, according to a filing with the SEC.

Javelin Venture Partners wraps up fourth fund at $125 mln

Javelin Venture Partners has closed its fourth fund at $125 million, according to an SEC filing. In October 2013, the venture firm raised $125 million for its third fund.